Technological advances in the field of genome sequencing are overcoming cost and speed limitations and opening the door to new applications, with third generation genome sequencers just around the corner.
It took nearly two decades to go from the release of the first semi-automated genome sequencer in the mid-1980s to the launch of Roche's flagship 454 FLX next generation sequencer in 2005. The 454 is now one of three major players in the next gen market whose impact on the world of genomics cannot be underestimated. Just five years later we are poised to embrace another new wave of sequencing technology.
Project to map Great Barrier Reef sponge reveals a more complex genome than first thought
It’s not normally something that would inspire scuba divers to do a double take, but a species of sponge commonly found on the Great Barrier Reef has researchers all in a lather at the prospect of learning about the genesis of cell behaviour.
Genome sequencing company, Illumina, launches global partnership to link researchers working in human genome sequencing projects.
Next-generation genome sequencing technology company, Illumina, today launched the Illumina Genome Network, which is a global partnership to link researchers working in human genome sequencing projects.
The $1000 genome is no longer just a lofty aspiration. The next generation of massively parallel, benchtop sequencers could see it realised within two years.
The $1000 genome is no longer just a lofty aspiration. The next generation of massively parallel, benchtop sequencers could see it realised within two years.
New kit helps paint truest picture of genome with longer reads and enhanced data quality.
Illumina today announced the launch of its TruSeq SBS Sequencing kit that will enable high-quality paired end reads of 150 base pairs (bp), increase the output of high-quality base calls, and enhance throughput to greater than 95 Gigabases (Gb) of high-quality base pairs per run on Illumina's Genome Analyzer (GA) sequencing system.
Tasmanian-born scientist, Dr Elizabeth Murchison, is using the latest next generation sequencing technology in an effort to rid the Tasmanian devil of the lethal facial tumours.
The devil facial tumour disease (DFTD) is a rare type of infectious cancer that threatens to rid Australia of one of its most iconic marsupials: the cute (sort of), and feisty (definitely), Tasmanian devil (Sarcophilus harrisii).
Search for keys to long life shifting away from single genes to more complex variations
A study of the genomes of 1000 centenarians in New England has highlighted 150 variations of DNA sequence which the researchers claim indicate with 77 percent accuracy whether someone will reach a century.
Australian researchers help solve the problem of 'missing heritability' by looking into the genetic basis of complex traits.
The Human Genome Project was supposed to shine a light on the phenomenon of heritability, illuminating how certain complex traits are passed down from parent to offspring.
New ARCS cloud service to provide researchers with easier access to the Australian Grid.
The Australian Research Collaboration Service (ARCS ) today launched its Computer Cloud, an initiative designed to give researchers faster and easier access to the Australian Grid network of high performance computers.
Latest version of popular software program features split screen and variation finder
New Zealand science software specialists Biomatters has released the latest version of its Geneious Pro sequence analysis software, which it says will allow users to achieve the full bacterial genome assembly for data from a range of leading sequencers using just a desktop computer.
Powerful genome barcoding system reveals large-scale variation in human DNA.
Genetic abnormalities are most often discussed in terms of single nucleotide polymorphisms, SNPs (pronounced "snips"), which are changes in a single unit along the 3 billion nucleotides that make up the entire string of human DNA.
Genome-wise association studies are proving unable to identify the key genetic differences associated with disease. Now researchers are suggesting a new approach to probing our DNA to reveal the causes of diseases.
When the full human genome was brought into the full light of day through the Human Genome Project, it was thought we could begin the task of uncovering the genetic bases of various diseases.
Detailed genome study on identical twins - one with MS - reveals no genetic trigger for the disease.
Monozygotic - or identical - twins have provided science with the ideal platform for distinguishing between genetic and environmental influences for anything from personality, risk of cardiovascular disease or even voting habits.
HiScanSQ modular microarray and next generation sequencer targeted at smaller labs.
Purchasing a microarray or next generation sequencers is no small investment. Now Illumina is hedging its bet by providing a single unit that incorporates both technologies, the HiScanSQ.
Researchers are filling the gaps in the human genome left by next generation sequencing.
Researchers have discovered 2,363 new DNA sequences corresponding to 730 regions on the human genome that were not charted in the reference map produced to date.
